Search Results

Filter
  • 1-10 of  524 results for ""Antirheumatic Agents""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?

  • Authors : Palacios CF; Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.; Chowdhary V

Subjects: Latent Tuberculosis*/Latent Tuberculosis*/Latent Tuberculosis*/diagnosis ; Latent Tuberculosis*/Latent Tuberculosis*/Latent Tuberculosis*/epidemiology ; Interferon-gamma Release Tests*/Interferon-gamma Release Tests*/Interferon-gamma Release Tests*/methods

  • Source: PloS one [PLoS One] 2024 Jul 03; Vol. 19 (7), pp. e0306337. Date of Electronic Publication: 2024 Jul 03 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Designing target trials using electronic health records: A case study of second-line disease-modifying anti-rheumatic drugs and cardiovascular disease outcomes in patients with rheumatoid arthritis.

  • Authors : Rivera AS; Institute for Public Health and Management, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, United States of America.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/complications ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Jun 14; Vol. 19 (6), pp. e0305467. Date of Electronic Publication: 2024 Jun 14 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Energy landscape analysis and time-series clustering analysis of patient state multistability related to rheumatoid arthritis drug treatment: The KURAMA cohort study.

  • Authors : Yamamoto K; Division of Data Science, Center for Industrial Research and Innovation, Translational Research Institute for Medical Innovation, Osaka Dental University, Hirakata City, Osaka, Japan.; Sakaguchi M

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use; Humans

  • Source: PloS one [PLoS One] 2024 May 06; Vol. 19 (5), pp. e0302308. Date of Electronic Publication: 2024 May 06 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Relapses of juvenile idiopathic arthritis in adulthood: A monocentric experience.

  • Authors : Scagnellato L; Rheumatology Unit, Department of Medicine DIMED, Padova University Hospital, Padova, Italy.; Cozzi G

Subjects: Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/drug therapy ; Recurrence* ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use

  • Source: PloS one [PLoS One] 2024 May 02; Vol. 19 (5), pp. e0298679. Date of Electronic Publication: 2024 May 02 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Biomarker combination predicting imminent relapse after discontinuation of biological drugs in patients with rheumatoid arthritis in remission.

  • Authors : Sakashita E; Department of Biochemistry, Jichi Medical University School of Medicine, Tochigi, Japan.; Nagatani K

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Biological Products*/Biological Products*/Biological Products*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Mar 21; Vol. 19 (3), pp. e0299450. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Burden of non-serious infections during biological use for rheumatoid arthritis.

  • Authors : Bergmans B; Tranzo, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands.; Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects; Adult

  • Source: PloS one [PLoS One] 2024 Feb 20; Vol. 19 (2), pp. e0296821. Date of Electronic Publication: 2024 Feb 20 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study.

  • Authors : Hai BB; Centre of Rheumatology, Bach Mai Hospital, Hanoi, Vietnam.; Anh TL

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/complications ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

  • Source: PloS one [PLoS One] 2024 Jan 11; Vol. 19 (1), pp. e0295048. Date of Electronic Publication: 2024 Jan 11 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Comparative analysis of multiorgan toxicity induced by long term use of disease modifying anti-rheumatic drugs.

  • Authors : Mumtaz T; Faculty of Science and Technology, Department of Zoology, Government College Women University, Faisalabad, Punjab, Pakistan.; Tahir A

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Renal Insufficiency*

  • Source: PloS one [PLoS One] 2023 Aug 25; Vol. 18 (8), pp. e0290668. Date of Electronic Publication: 2023 Aug 25 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

JAK-inhibitors and risk on serious viral infection, venous thromboembolism and cardiac events in patients with rheumatoid arthritis: A protocol for a prevalent new-user cohort study using the Danish nationwide DANBIO register.

Subjects: Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/chemically induced ; Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/epidemiology ; Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/drug therapy

  • Source: PloS one [PLoS One] 2023 Jul 27; Vol. 18 (7), pp. e0288757. Date of Electronic Publication: 2023 Jul 27 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Safety and efficacy of mesenchymal stem cells therapy in the treatment of rheumatoid arthritis disease: A systematic review and meta-analysis of clinical trials.

  • Authors : Mesa LE; BioXcellerator / BioXscience Advanced Therapies and Translational Medicine, Medellín, Antioquia, Colombia.; López JG

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy; Humans

  • Source: PloS one [PLoS One] 2023 Jul 27; Vol. 18 (7), pp. e0284828. Date of Electronic Publication: 2023 Jul 27 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
  • 1-10 of  524 results for ""Antirheumatic Agents""